Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

October 2020 Issue of The Medicine Maker

In this month’s issue of The Medicine Maker, we sit down with Richard M. Johnson, President, and Chief Executive Officer of the Parenteral Drug Association, who shares some career-defining experiences with us. In Business, we examine the state of US pharma and what the upcoming election could mean for the industry. Kiran Mazumdar-Shaw also shares the story behind Biocon’s biopharmaceutical success. In NextGen, we ask Duncan Peyton, Chief Executive Officer at 4D pharma about the importance of live biotherapeutics, and in our cover feature, we explore the challenges and opportunities that await African pharma.

Download Issue

Register here to download any issue of The Medicine Maker for FREE.

Login

Or register now - it’s free!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

When you click “Register” we will email you a link, which you must click to verify the email address above and activate your account. If you do not receive this email, please contact us at [email protected].

Articles featured in this issue

Manufacture Quality & Compliance

Animal Alternatives

| Maryam Mahdi

How can we reduce animal testing in quality control procedures?

Manufacture Technology and Equipment

Top Tier Innovation

Nominate the top pharmaceutical technologies in our 2020 Innovation Awards.

Manufacture Formulation

The Drug Dose Gender Gap

| Maryam Mahdi

How can we achieve gender parity in drug dosing?

Manufacture Vaccines

Don’t Exclude the Aged

| Stephanie Sutton

Most clinical trials against COVID-19 exclude the very patients most at risk from the disease.

Business & Regulation Standards & Regulation

Importation Action

| Stephanie Sutton

How will new guidance issued by the FDA affect drug importation?

Discovery & Development Drug Discovery

A Model Experiment

| Audrey Dubourg

Harnessing the potential of microphysiological systems to advance drug discovery.

Manufacture Quality & Compliance

Zero Defects

| Massimo Mainetti

Lives and livelihoods depend on accelerating large molecule drug production, so biopharma companies must minimize defects and contamination.

Focus on Quality – and the Rest Will Follow

| Sponsored by Thermo Fisher Scientific

Amgen developed the Multi-Attribute Method (MAM) to obtain high-fidelity understanding of the quality of its own biologics. Click to read article

Business & Regulation Profession

A Wealth of Experience

Sitting Down With… Richard M. Johnson, President, and Chief Executive Officer, Parenteral Drug Association.

Other issues of 2020